India records over 8,000 fresh Covid-19 infections, 119 more fatalities

The daily positivity rate has been recorded at 1.11 per cent, while the weekly positivity rate has been recorded at 1.17 per cent

Topics
Coronavirus Vaccine | Coronavirus Tests

Press Trust of India  |  New Delhi 

A health worker testing for Covid-19 collects the swab sample of a passenger at a railway station in Mumbai on January 18, 2022. (PTI Photo/Shashank Parade)
A health worker testing for Covid-19 collects the swab sample of a passenger at a railway station in Mumbai on January 18, 2022. (PTI Photo/Shashank Parade)

The single-day rise in infections fell below 10,000 after two months, with 8,013 cases taking India's total tally to 4,29,24,130, while active cases have declined to 1,02,601, according to Union health ministry data updated on Monday.

On December 28 last year, 9,195 people were infected in a day.

The death toll has climbed to 5,13,843 with 119 daily fatalities, the data updated at 8 am stated.

The daily COVID-19 cases have been recorded at less than one lakh for 22 consecutive days.

The active cases comprise 0.24 per cent of the total infections, while the national COVID-19 recovery rate has further improved to 98.56 per cent, the health ministry said.

A reduction of 8,871 cases has been recorded in the active COVID-19 caseload in a span of 24 hours, it said.

The daily positivity rate has been recorded at 1.11 per cent, while the weekly positivity rate has been recorded at 1.17 per cent, according to the health ministry.

The number of people who have recuperated from the disease increased to 4,23,07,686, while the case fatality rate has been recorded at 1.20 per cent.

The cumulative doses administered so far under the nationwide COVID-19 vaccination drive has exceeded 177.50 crore.

India's COVID-19 tally had crossed two crore cases on May 4 and three crore cases on June 23.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus Vaccine
First Published: Mon, February 28 2022. 11:25 IST
RECOMMENDED FOR YOU